The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers.
about
Cyclin D as a therapeutic target in cancerThe noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cellThe genomic landscape of testicular germ cell tumours: from susceptibility to treatment.Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity.Identifying differential networks based on multi-platform gene expression data.Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance.A unique combination of male germ cell miRNAs coordinates gonocyte differentiation.Transcription-mediated chimeric RNAs in prostate cancer: time to revisit old hypothesis?Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancerEvaluation of cloned cells, animal model, and ATRA sensitivity of human testicular yolk sac tumorGerm cell pluripotency, premature differentiation and susceptibility to testicular teratomas in miceAlterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy.Investigation of the anti-cancer effect of quercetin on HepG2 cells in vivoAssociation between the Cyclin D1 G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysisGenome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators.Misexpression of cyclin D1 in embryonic germ cells promotes testicular teratoma initiation.Cyclin D1 affects epithelial-mesenchymal transition in epithelial ovarian cancer stem cell-like cellsDeregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin.CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity.c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.Testicular germ cell tumours: predisposition genes and the male germ cell niche.Molecular genetics of testicular germ cell tumors.The 11q13-q14 amplicon: clinicopathological correlations and potential drivers.Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer.Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells.Postchemotherapy changes in testicular germ cell tumours: biology and morphology.Quercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer.Identification of ZDHHC14 as a novel human tumour suppressor gene.Let-7b expression determines response to chemotherapy through the regulation of cyclin D1 in glioblastomaLncRNA HOTAIR promotes cisplatin resistance in gastric cancer by targeting miR-126 to activate the PI3K/AKT/MRP1 genes.Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancerRapamycin inhibits prostate cancer cell growth through cyclin D1 and enhances the cytotoxic efficacy of cisplatin.Acquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement of resistance genes.Phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors.High frequency of the SDK1:AMACR fusion transcript in Chinese prostate cancer.Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis.Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways.Post-transcriptional Regulation of Genes Related to Biological Behaviors of Gastric Cancer by Long Noncoding RNAs and MicroRNAs.Cyclin D1 depletion induces DNA damage in mantle cell lymphoma lines.Identification of genes and pathways associated with MDR in MCF-7/MDR breast cancer cells by RNA-seq analysis.
P2860
Q28242623-5C9EEFFE-92AB-4B72-9083-873E6B2D747AQ28533535-523986D3-0484-4414-A196-F189600AD584Q30249650-54EF2264-E704-42EF-966F-B4F24527DFC4Q30313117-3F665CC9-57DD-4A63-A5E4-469ACD83E97AQ31143551-A64EAA0D-41B3-4E1F-BD0C-27BD912F4088Q33896475-1098DBB9-3EA4-4B1A-8899-35DE0E9FC120Q34247366-DCCD633C-BA20-4BB8-A44E-3B20EC4B70B0Q34247934-41F3F3C5-0CB5-468F-8E8C-CE665EAE7ADFQ35562928-AD1E0E70-F090-4B22-99E6-CB0FAAFFC65AQ35858428-5179C05E-2643-45AD-9E6A-C211679EE420Q35866515-D1EB2C74-27F7-43C6-A8D2-D40CFC968693Q35917703-0E2020C1-8453-421B-AC81-9EDB2542455BQ36298367-5ABB5D08-DF34-4CFE-B591-641028171D01Q36504154-F416E9F7-EA04-4A71-A957-D799DEBD484FQ36583705-9A3163BD-DC04-43C1-998D-61D27295F5CBQ36956953-56935C7D-E37A-4D32-91B5-DE2F22B78C10Q36975824-57A792D6-6CEC-425C-BA73-6F5CE4D63A8FQ37275739-00147996-265A-4D1F-AAD8-F253D2103D9EQ37586623-19BEF0FE-613E-406B-94E1-C148304A8881Q37833424-F7D4CB9C-727B-4A52-87C2-08E87BB23921Q37853838-23675074-E2A9-437A-86C8-7B8DB29CA81FQ37995190-AEF9486E-7583-4D48-9A1A-526EE6D2B039Q38066149-50686688-8356-4EBB-B4DD-C28C51B9FDF3Q38145508-1B5AAA93-819E-4CD0-A21A-CB67BCA2D6B6Q38771876-8F452F2C-DE37-4644-B35A-37CD0B076011Q38783396-648EAF45-FE9C-4A8D-99BA-702BFD86E261Q38875616-A9895712-A06B-40AB-B979-06C1C8E93CE9Q39035797-E4BA2327-34D5-4015-B0CB-C5F73EBDCD53Q39134240-482206D2-16BF-4EA0-82CB-7E4788DF03EFQ39143857-A141D6B3-8DDC-4A0A-A65C-5E9E41F84AFBQ39241495-81D42202-1A5D-49C4-9BEB-9F72AC539933Q40970978-C37F31F7-D1FC-4FFC-A438-43BA0BA38C3AQ42351657-C92152CD-E734-48C9-AAD5-FD7E659EFF49Q42703146-12EE8D0A-3031-4BBA-90DF-3B8333ACB63DQ43156871-81F5E654-E280-4C58-B746-95B4E65D4F5BQ44221016-2328CB26-7708-4510-B37D-9869AC45F107Q47103726-DDC6ABB8-07A8-48FC-BF4C-F59C6E51E97DQ47149869-7D099D61-BEFB-495F-8DFD-02D53584D9C4Q47615901-95738FD1-DEF8-40B7-9E5F-CAF5656A4AEAQ52669994-5705ED93-3670-4B06-B4FE-6997A3D65D8C
P2860
The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The association of CCND1 overe ...... cell tumors and other cancers.
@ast
The association of CCND1 overe ...... cell tumors and other cancers.
@en
type
label
The association of CCND1 overe ...... cell tumors and other cancers.
@ast
The association of CCND1 overe ...... cell tumors and other cancers.
@en
prefLabel
The association of CCND1 overe ...... cell tumors and other cancers.
@ast
The association of CCND1 overe ...... cell tumors and other cancers.
@en
P2093
P2860
P1476
The association of CCND1 overe ...... cell tumors and other cancers.
@en
P2093
Alan McIntyre
Bryan D Young
Daniel M Berney
Elodie E Noel
Jackie Perry
Janet Shipley
Marc Yeste-Velasco
Ningfeng F Li
P2860
P304
P356
10.2353/AJPATH.2010.090780
P407
P577
2010-04-15T00:00:00Z